Feed / TMDX

TransMedics Group, Inc.

TMDX

Healthcare · 94.95 +4.7% today

Isolated · not yet confirmedMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

TransMedics Group, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.

Company+4.7% todayVolume comparison unavailable
Market group0 of 1 activeOrgan Transplant Technology · unavailable
Disclosed network0 of 2 confirmingNo filing-linked name is confirming now
What would change this read
  • Revenue from U.S. customers related to OCS transplant was $167.0 million for the quarter, up $28.4 million year-over-year driven by higher OCS Liver disposable set volumes and increased NOP usage.
  • Gross margin from net product revenue decreased year-over-year, primarily attributed to product mix and higher freight costs.

Invalidation: The isolated read changes if TMDX's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind TMDX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

BTIBritish American Tobacco p.l.c.competitorFeb 24, 2026

Sometimes the relevant rules are found in industry guidance rather than legislation—for example, relationships with healthcare professionals in the UK are governed by the code of Association of British HealthTech Industries, or ABHI, and rules may limit or re…

Depended on by

HTGCHercules Capital, Inc.investeeOct 30, 2025

The net realized gains (losses) were generated from gross realized gains of $2.8 million and $17.8 million respectively, for the three and nine month periods, primarily from the sale of our equity and warrant positions in Palantir Technologies, TransMedics Gr…

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

TMDX is currently a Leader in the organic co-movement group Organ Transplant Technology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for TMDX; it is not active in the latest market snapshot.